Marcus A Wörns Selected Research

Marcus A Wörns Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2014
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2012
4	Liver Neoplasms (Liver Cancer) 01/2019 - 03/2014
4	Fibrosis (Cirrhosis) 03/2016 - 08/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 05/2015
3	Ascites 10/2022 - 05/2013
3	Inflammation (Inflammations) 01/2018 - 05/2015
3	Liver Diseases (Liver Disease) 01/2018 - 01/2008
2	Alcoholic Fatty Liver 10/2022 - 12/2016
2	Infections 10/2022 - 01/2008
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 05/2012
2	Liver Failure 01/2018 - 04/2015
2	Hepatitis C 03/2016 - 07/2007
2	Reinfection 07/2014 - 07/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2022
1	Hepatic Encephalopathy 10/2022
1	Tics (Tic) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Cholestasis 01/2018
1	Insulin Resistance 12/2016
1	Chronic Hepatitis C 08/2015
1	End Stage Liver Disease 05/2015
1	Pruritus (Itching) 07/2014
1	Hypersensitivity (Allergy) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Hepatitis 01/2008
1	Hepatitis A (Hepatitis, Infectious) 01/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2006
1	Hepatolenticular Degeneration (Wilson's Disease) 08/2006
1	Diarrhea 08/2006
1	Chronic Hepatitis B 08/2006
1	Autoimmune Hepatitis 08/2006
1	Cryptogenic Cirrhosis 08/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2012
4	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 05/2013
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 02/2016
2	CaspasesIBA 01/2022 - 05/2012
2	CytokinesIBA 01/2018 - 01/2018
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2018 - 08/2012
2	Antiviral Agents (Antivirals)IBA 03/2016 - 07/2014
2	SofosbuvirIBA 03/2016 - 08/2015
2	AntibodiesIBA 05/2015 - 01/2014
2	Ribavirin (Virazole)FDA LinkGeneric 07/2014 - 07/2007
2	InterferonsIBA 07/2014 - 07/2007
1	Vitamin A (Retinol)FDA LinkGeneric 10/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2020
1	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 01/2019
1	Ginkgo biloba extract (Rokan)IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 12/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2017
1	JNK Mitogen-Activated Protein KinasesIBA 08/2017
1	Fetal Proteins (Fetoprotein)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 12/2016
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 12/2016
1	Insulin (Novolin)FDA Link 12/2016
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Messenger RNA (mRNA)IBA 02/2016
1	Organic Cation Transporter 1IBA 02/2016
1	resminostatIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 08/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2015
1	SirtuinsIBA 04/2015
1	Erythropoietin FDA Link 07/2014
1	Silybin (Lagosa)IBA 07/2014
1	catumaxomabIBA 01/2014
1	Caspase 8 (Caspase-8)IBA 08/2012
1	Thioacetamide (Thioacetamid)IBA 08/2012
1	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2012
1	Surface Antigens (Surface Antigen)IBA 01/2008
1	VaccinesIBA 01/2008
1	Hepatitis B Core AntigensIBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2006
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2006

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2006
5	Liver Transplantation 05/2015 - 08/2006
1	Ligation 01/2018
1	Retreatment 01/2017
1	Contraindications 04/2015
1	Radiotherapy 04/2015
1	Punctures 01/2014